MedPath

Crozer-Keystone Health System

🇺🇸United States
Ownership
-
Established
1990-01-01
Employees
-
Market Cap
-
Website
http://www.crozer.org

Clinical Trials

3

Active:1
Completed:1

Trial Phases

3 Phases

Phase 2:1
Phase 3:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (33.3%)
Phase 2
1 (33.3%)
Phase 3
1 (33.3%)

Immunotherapy SBRT Sensitization of the Programmed Death-1 (PD-1) Effect

Phase 2
Completed
Conditions
Metastatic Nonsmall Cell Lung Cancer
Non Small Cell Lung Cancer
First Posted Date
2019-01-31
Last Posted Date
2023-03-06
Lead Sponsor
Crozer-Keystone Health System
Target Recruit Count
3
Registration Number
NCT03825510
Locations
🇺🇸

Philadelphia CyberKnife, Philadelphia, Pennsylvania, United States

CyberKnife Dose Escalation Prostate Cancer Trial

Not Applicable
Active, not recruiting
Conditions
Prostate Neoplasm
Prostate Cancer
Prostate Adenocarcinoma
First Posted Date
2019-01-30
Last Posted Date
2025-02-21
Lead Sponsor
Crozer-Keystone Health System
Target Recruit Count
100
Registration Number
NCT03822494
Locations
🇺🇸

Philadelphia CyberKnife, Philadelphia, Pennsylvania, United States

Reactor Thoracostomy

Phase 3
Conditions
Pneumothorax
Hemothorax
First Posted Date
2018-11-08
Last Posted Date
2018-11-08
Lead Sponsor
Crozer-Keystone Health System
Target Recruit Count
54
Registration Number
NCT03734471

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.